SLC18A2 and central nervous system cancer: Abnormal SLC18A2 expression may also affect GB cells, since neuronal activity promotes glioma formation through autocrine, non-synaptic, as well as synaptic paracrine mechanisms using functional synapses between glioma cells and neurons, inducing tumor proliferation and progression [82].